Organogenesis Holdings Inc.
ORGO
$2.61
$0.030.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 77.70% | 30.66% | -22.62% | -21.17% | 27.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.13% | 30.98% | -22.44% | -21.17% | 27.10% |
| Cost of Revenue | 60.76% | 35.29% | -5.37% | -17.33% | 11.82% |
| Gross Profit | 83.77% | 29.68% | -27.38% | -22.53% | 33.00% |
| SG&A Expenses | 35.63% | 10.35% | -3.57% | 0.26% | 24.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.74% | 18.14% | -7.82% | -6.11% | 17.61% |
| Operating Income | 538.31% | 255.09% | -221.56% | -423.86% | 1,474.58% |
| Income Before Tax | 518.62% | 263.39% | 18.61% | -493.67% | 670.88% |
| Income Tax Expenses | 664.61% | 93.75% | -197.56% | -209.41% | 310.10% |
| Earnings from Continuing Operations | 469.53% | 74.90% | 44.89% | -797.29% | 1,450.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 469.53% | 74.90% | 44.89% | -797.29% | 1,450.88% |
| EBIT | 538.31% | 255.09% | -221.56% | -423.86% | 1,474.58% |
| EBITDA | 377.86% | 153.95% | -147.72% | -13,234.71% | 201.75% |
| EPS Basic | 510.82% | 23.12% | 50.78% | -975.47% | 1,153.49% |
| Normalized Basic EPS | 551.62% | 304.73% | -227.76% | -361.65% | 8,133.33% |
| EPS Diluted | 514.71% | 22.22% | 50.23% | -755.00% | 1,032.56% |
| Normalized Diluted EPS | 497.53% | 296.69% | -227.76% | -361.65% | 7,983.33% |
| Average Basic Shares Outstanding | -2.13% | -4.29% | -4.31% | -4.22% | -0.95% |
| Average Diluted Shares Outstanding | 6.65% | -2.30% | -4.31% | -4.22% | 0.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |